Salvatore Babones speaks with James McBrayer, CEO of the listed medical technology company Cyclopharm and CIS Member. James’s company is rare in that it still manufactures here in Australia. The local production line manufactures and distributes the components to several of its products including Technegas, a radio-pharmaceutical used in lung ventilation imaging.
We’ll be asking James about how his company’s products may help fight the coronavirus, the regulatory complexities in operating across jurisdictions and the impact of the variations among healthcare systems. James and Salvatore will also address the current challenges posed for medical supply chains with increased demand across the sector.